World news, news around town, tech update 3
Ad
Friday, 24 March 2017
EMA panel backs Novo Nordisk's hemophilia B drug
(Reuters) - A panel of the European Medicines Agency said it recommended granting marketing approval to Danish drugmaker Novo Nordisk's hemophilia B drug.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment